WWMSC
PCRX icon

Wagner Wealth Management (South Carolina)’s Pacira BioSciences PCRX Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$1K – 577
2022
Q3 		$1K Buy
+10
New +$556 ﹤0.01% 655

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s PCRX Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of Pacira BioSciences (PCRX) in Q4 2022, closing a stake of 10 shares — an estimated $1K sold.

Wagner Wealth Management (South Carolina) first reported a position in PCRX in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 272 funds tracked by Wall St. Rank hold PCRX as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining Pacira BioSciences position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 10 Pacira BioSciences shares in Q4 2022, an estimated $1K.
  • Wagner Wealth Management (South Carolina) first reported a position in Pacira BioSciences in Q3 2022 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s Pacira BioSciences position peaked at $1K in Q3 2022.
  • 272 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.